Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] Company Summaries Flywire Corporation (NASDAQ: FLYW) - Class Period: February 28, 2024 – February 25, 2025 - Lead Plaintiff Deadline: September 23, 2025 - Allegations include overstating revenue growth sustainability, underestimating the impact of permit and visa restrictions, and misleading positive statements about business operations [2] Lockheed Martin Corporation (NYSE: LMT) - Class Period: January 23, 2024 – July 21, 2025 - Lead Plaintiff Deadline: September 26, 2025 - Allegations include lack of effective internal controls, inaccurate program reviews, overstated contract delivery capabilities, and misleading positive statements about business prospects [3] Sable Offshore Corp. (NYSE: SOC) - Class Period: May 19, 2025 – June 3, 2025 - Lead Plaintiff Deadline: September 26, 2025 - Allegations include false claims about restarting oil production and misleading positive statements regarding business operations [4] Novo Nordisk A/S (NYSE: NVO) - Class Period: May 7, 2025 – July 28, 2025 - Lead Plaintiff Deadline: September 30, 2025 - Allegations include ignoring the significance of personalization exceptions for GLP-1 compounding and misleading statements about the company's ability to capture patient populations [5]

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and failure to disclose critical information during designated class periods [1]. Company Summaries Hims & Hers Health, Inc. (NYSE: HIMS) - Class Period: April 29, 2025 – June 23, 2025 - Lead Plaintiff Deadline: August 25, 2025 - Allegations include deceptive promotion of illegitimate versions of Wegovy, risking patient safety, and potential termination of collaboration with Novo Nordisk, leading to materially misleading statements about the company's business and prospects [2]. iRobot Corporation (NASDAQ: IRBT) - Class Period: January 29, 2024 – March 11, 2025 - Lead Plaintiff Deadline: September 5, 2025 - Allegations state that iRobot overstated the effectiveness of its Restructuring Plan post-Amazon Acquisition, raising doubts about its ability to operate profitably as a standalone entity, resulting in misleading statements regarding its business and operations [3]. Centene Corporation (NYSE: CNC) - Class Period: December 12, 2024 – June 30, 2025 - Lead Plaintiff Deadline: September 8, 2025 - Allegations indicate that a preliminary analysis revealed lower-than-expected enrollment and increased market morbidity, leading to misleading statements about the company's business and prospects [4].

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific allegations of misleading statements and undisclosed risks during designated class periods [1][2][3][4][5]. Group 1: Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) - Class period is from February 27, 2025, to May 26, 2025, with a lead plaintiff deadline of August 11, 2025 [2]. - Allegations include that Rocket was aware of serious adverse events (SAEs), including participant deaths, and failed to disclose this risk [2]. - The company amended trial protocols without informing shareholders, leading to misleading positive statements about its business and prospects [2]. Group 2: 3D Systems Corporation (NYSE: DDD) - Class period is from August 13, 2024, to May 12, 2025, with a lead plaintiff deadline of August 12, 2025 [3]. - Allegations state that 3D Systems understated the impact of reduced customer spending and overstated its resilience in tough industry conditions [3]. - The updated milestone criteria negatively impacted the company's Regenerative Medicine Program revenue, resulting in misleading statements about its business outlook [3]. Group 3: Tempus AI, Inc. (NASDAQ: TEM) - Class period is from August 6, 2024, to May 27, 2025, with a lead plaintiff deadline of August 12, 2025 [4]. - Allegations include inflation of contract values and risks associated with the joint venture with SoftBank, which appeared to involve "round-tripping" capital [4]. - Concerns were raised about the business model of Tempus-acquired Ambry, which was based on aggressive billing practices, and reduced financial commitments from AstraZeneca [4]. Group 4: Reddit, Inc. (NYSE: RDDT) - Class period is from October 29, 2024, to May 20, 2025, with a lead plaintiff deadline of August 18, 2025 [5]. - Allegations indicate that changes in Google Search algorithms led to decreased traffic to Reddit, which was not disclosed to investors [5]. - The company misrepresented its user rates and advertising revenue outlook, failing to acknowledge the impact of zero-click searches on its traffic [5].